World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
57
Citations
18839
World Ranking
2126
National Ranking
1054

Patricia L. M. Dahia publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Patricia L. M. Dahia sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 142 publications — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Patricia L. M. Dahia D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Patricia L. M. Dahia sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 57 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Patricia L. M. Dahia is affiliated with The University of Texas Health Science Center at San Antonio in the United States. Their research predominantly spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions to Surgery, Cancer Research, Molecular Biology, Endocrinology, Diabetes and Metabolism, and Neurology.

Dahia's scientific work primarily addresses topics including Adrenal and Paraganglionic Tumors, Cancer, Hypoxia, and Metabolism, Hormonal Regulation and Hypertension, Neuroblastoma Research and Treatments, Pituitary Gland Disorders and Treatments, Immune Cell Function and Interaction, and Ubiquitin and Proteasome Pathways.

Recent publications by Patricia L. M. Dahia include:

  • International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers, 2021, Nature Reviews Endocrinology
  • A membrane-associated MHC-I inhibitory axis for cancer immune evasion, 2023, Cell
  • The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma, 2021, Pancreas
  • Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia, 2022, Endocrine Reviews
  • Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment, 2022, Nature Communications

Dahia collaborates regularly with several researchers, frequently co-authoring papers with Qianjin Guo, Ricardo C.T. Aguiar, Roderick Clifton-Bligh, Anne-Paule Gimenez-Roqueplo, and Camilo Jiménez.

Their work is published in venues such as bioRxiv (Cold Spring Harbor Laboratory), Nature Communications, Cancers, Journal of the Endocrine Society, and Nature Reviews Endocrinology, indicating an ongoing engagement with both pre-print and peer-reviewed platforms.

Best Publications

  • Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome

    D. Liaw;D. J. Marsh;J. Li;P. L M Dahia

  • Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma

    Dewi Astuti;Farida Latif;Ashraf Dallol;Patricia L.M. Dahia

  • Mutation Spectrum and Genotype-Phenotype Analyses in Cowden Disease and Bannayan-Zonana Syndrome, Two Hamartoma Syndromes With Germline PTEN Mutation

    Debbie J. Marsh;Valérie Coulon;Kathryn L. Lunetta;Philippe Rocca-Serra

  • Germline mutations in PTEN are present in Bannayan-Zonana syndrome.

    Debbie J. Marsh;Patricia L. M. Dahia;Zimu Zheng;Danny Liaw

  • Clinical presentation and penetrance of Pheochromocytoma/ Paraganglioma syndromes.

    Diana E. Benn;Anne Paule Gimenez-Roqueplo;Jennifer R. Reilly;Jérôme Bertherat

  • PTEN Mutation Spectrum and Genotype-Phenotype Correlations in Bannayan-Riley-Ruvalcaba Syndrome Suggest a Single Entity With Cowden Syndrome

    Debbie J. Marsh;Debbie J. Marsh;Jennifer B. Kum;Jennifer B. Kum;Kathryn L. Lunetta;Michael J. Bennett

  • Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations

    Katherine A. Janeway;Su Young Kim;Maya Lodish;Vânia Nosé

  • Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity.

    Patricia L M Dahia

  • Immunohistochemical Evidence of Loss of PTEN Expression in Primary Ductal Adenocarcinomas of the Breast

    Aurel Perren;Liang Ping Weng;Alexander H. Boag;Ulricke Ziebold

  • A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas

    Patricia L. M. Dahia;Ken N Ross;Matthew E Wright;Cesar Y. Hayashida

  • Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08

    Patrick Y. Wen;W. K Alfred Yung;Kathleen R. Lamborn;Patricia L. Dahia

  • Germline mutations in TMEM127 confer susceptibility to pheochromocytoma

    Yuejuan Qin;Li Qin Yao;Elizabeth E. King;Kalyan Buddavarapu

  • PTEN Is Inversely Correlated With the Cell Survival Factor Akt/PKB and Is Inactivated Via Multiple Mechanisms in Haematological Malignancies

    Patricia L M Dahia;Ricardo C T Aguiar;John Alberta;Jennifer B. Kum

  • The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor

    Susanne Schlisio;Rajappa S. Kenchappa;Liesbeth C.W. Vredeveld;Rani E. George

  • PTEN Suppresses Breast Cancer Cell Growth by Phosphatase Activity-dependent G1 Arrest followed by Cell Death

    Liang Ping Weng;Wendy M. Smith;Patricia L M Dahia;Ulrike Ziebold

  • PTEN, a unique tumor suppressor gene.

    P. L.M. Dahia

  • MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma

    Nelly Burnichon;Alberto Cascón;Francesca Schiavi;Nicole Paes Morales

  • An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes.

    A. P. Gimenez-Roqueplo;A. P. Gimenez-Roqueplo;P. L. Dahia;M. Robledo

  • Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors

    Patricia L M Dahia;Debbie J. Marsh;Zimu Zheng;Jan Zedenius

  • Targeting of SMAD5 links microRNA-155 to the TGF-β pathway and lymphomagenesis

    Deepak Rai;Sang Woo Kim;Morgan R. McKeller;Patricia L M Dahia

Frequent Co-Authors

Charis Eng
Charis Eng Cleveland Clinic Lerner College of Medicine
Ashley B. Grossman
Ashley B. Grossman University of Oxford
Eamonn R. Maher
Eamonn R. Maher University of Cambridge
Bruce G. Robinson
Bruce G. Robinson University of Sydney
Charles D. Stiles
Charles D. Stiles Harvard University
Lois M. Mulligan
Lois M. Mulligan Queen's University
Neil Aronin
Neil Aronin University of Massachusetts Chan Medical School
Ian Tomlinson
Ian Tomlinson University of Oxford
Ramon Parsons
Ramon Parsons Icahn School of Medicine at Mount Sinai
Karel Pacak
Karel Pacak National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring molecular biology opens doors to a wide range of career paths, especially as online education continues to expand. Those interested in support roles may consider a human services bachelors degree online, which can complement a science background by preparing students for work in healthcare or social services.

For students drawn to communication disorders and healthcare, understanding the education required to be a speech pathologist can highlight specialized pathways needing foundational biology knowledge.

Science and math skills gained in molecular biology also transfer well to technical design roles. Top online architecture degree programs often emphasize problem-solving, scientific reasoning, and data analysis—skills shared with molecular biology grads.

Mathematical reasoning is key to both research and applied scientific roles. Earning one of the online math degree programs may further broaden career options in bioinformatics, biotech, and beyond.

Best Scientists Citing Patricia L. M. Dahia

Trending Scientists